Insider · CIK 0001828602
Massimo Calafiore
Files at OFIX (Orthofix Medical Inc.). First filing Jan 14, 2025, latest Mar 6, 2026.
Massimo Calafiore files SEC Form 4 as CEO, president and director at OFIX (Orthofix Medical Inc.). Since Jan 14, 2025, Massimo Calafiore has reported 2 open-market buys worth $298k and 3 open-market sells worth $784k, the latest filed on Mar 6, 2026.
A track record needs three past buys with six months of prices behind them; Massimo Calafiore has 0, so none is measured yet.
The newest scored trade: sold $156k of OFIX on Mar 4, 2026, filed Mar 6, 2026, scored 51 (moderate). In the last 12 months: 0 buys worth $0 and 2 sells worth $457k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OFIX: Orthofix Medical Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | Orthofix Medical Inc. | $156k 12,220 shares | -4% | +24% from low-26% from high | |
| 47Moderate | Orthofix Medical Inc. | $301k 19,397 shares | -8% | +53% from low-17% from high | |
| 74Notable | Orthofix Medical Inc. | $125k 10,000 shares | +4% | +1% from low-40% from high | |
| 36Weak | OFIXbuy Orthofix Medical Inc. | $173k 9,914 shares | +5% | - | |
| 60Notable | Orthofix Medical Inc. | $327k 19,281 shares | -13% | - |
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | OFIX Orthofix Medical Inc. | SOpen-market sale Common Stock | -6,189 | $12.92 | $80k | 326,167 | Mar 6, 2026 |
| Mar 5, 2026 | OFIX Orthofix Medical Inc. | SOpen-market sale Common Stock | -6,031 | $12.55 | $76k | 320,136 | Mar 6, 2026 |
| Mar 3, 2026 | OFIX Orthofix Medical Inc. | AGrant or award Common Stock | +115,119 | $0.00 | $0 | 332,356 | Mar 5, 2026 |
| Mar 3, 2026 | OFIX Orthofix Medical Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +273,279 | $0.00 | $0 | 273,279 | Mar 5, 2026 |
| Jan 9, 2026 | OFIX Orthofix Medical Inc. | SOpen-market sale Common Stock | -9,600 | $15.82 | $152k | 227,034 | Jan 13, 2026 |
| Jan 12, 2026 | OFIX Orthofix Medical Inc. | SOpen-market sale Common Stock | -9,797 | $15.21 | $149k | 217,237 | Jan 13, 2026 |
| May 9, 2025 | OFIX Orthofix Medical Inc. | POpen-market purchase Common Stock | +10,000 | $12.54 | $125k | 234,603 | May 12, 2025 |
| Mar 5, 2025 | OFIX Orthofix Medical Inc. | POpen-market purchase Common Stock | +9,914 | $17.43 | $173k | 222,404 | Mar 6, 2025 |
| Mar 3, 2025 | OFIX Orthofix Medical Inc. | AGrant or award Common Stock | +88,339 | $0.00 | $0 | 212,490 | Mar 5, 2025 |
| Mar 3, 2025 | OFIX Orthofix Medical Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +209,541 | $0.00 | $0 | 209,541 | Mar 5, 2025 |
| Jan 10, 2025 | OFIX Orthofix Medical Inc. | SOpen-market sale Common Stock | -10,078 | $16.83 | $170k | 133,354 | Jan 14, 2025 |
| Jan 13, 2025 | OFIX Orthofix Medical Inc. | SOpen-market sale Common Stock | -9,203 | $17.14 | $158k | 124,151 | Jan 14, 2025 |
Questions about Massimo Calafiore
Answered from the filings on this page, as of the latest one.
Is Massimo Calafiore buying or selling?
In the last 12 months Massimo Calafiore reported 0 open-market buys worth $0 and 2 open-market sells worth $457k on SEC Form 4; the latest was sold $156k of OFIX on Mar 4, 2026. Grants, option exercises and tax withholding are not counted.
How did Massimo Calafiore's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Massimo Calafiore has 0.
Where does Massimo Calafiore file Form 4?
Massimo Calafiore has filed Form 4 at OFIX (Orthofix Medical Inc.) as President & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.